Postoperative mortality in peritoneal dialysis: analytic study in patients with peritonitis

AJBM crossMark


Volume 10, Issue 2, May 17 2022, Pages 72-81

Wi-Young Sung, Jinkyung Choi1*



The number of patients with end-stage renal disease (ESRD) who receive peritoneal dialysis (PD) therapy has been increasing worldwide because of the improvement in PD techniques and concomitant patient survival. PD-related peritonitis remains the leading cause of technique failure in PD therapy. The purpose of this study is to analysis the risk factors that lead to mortality in patients receiving PD who needs surgery. Retrospective study included 44 patients with peritoneal dialysis (PD) subjects to elective surgery for peritonitis. Collected data regarding demographic analysis, number of PD followed by peritonitis episodes, type of surgical operation and mortality due to peritonitis. The resulted data explained that PD with gastrointestinal surgery resulted with peritonitis were encountered in 10 patients and PD with cirrhosis patients increased mortality in old patients (p = 0.02). However, mortality increased with old age in patients with ischemic heart disease (p = 0.004). Furthermore, the results of binary logistic regression analysis for age (odds ratio [OR]= 1.09; 95% Cl [1.012-1.193]; p=0.012), ischemic heart diseases [OR] = 52.1; 95% Cl [5.192-433.631]; p=0.011. In conclusions surgical operations that performed in peritonitis patients due to PD needs experienced centers with professional staff.

Keywords: End-stage renal disease; Peritoneal dialysis; Peritonitis

Copyright © 2022 Choi J, et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Article citationReferencesFull-Text/PDFBecome reviewer
The citation data is computed by the following citation measuring services:

Cited by (CrossRef)
Google Scholar

1. Saran R, Robinson B, Abbott KC, et al. US renal data system 2019 annual data report: epidemiology of kidney disease in the United States. Am J Kidney Dis 2020;75(1 Suppl 1):A6-A7.

2. Teitelbaum I, Burkart J. Peritoneal dialysis. Am J Kidney Dis 2003; 42:1082.
3. McCormick BB, Bargman JM. Noninfectious complications of peritoneal dialysis: implications for patient and technique survival. J Am Soc Nephrol 2007; 18:3023.
4. Berns JS, Tokars JI. Preventing bacterial infections and antimicrobial resistance in dialysis patients. Am J Kidney Dis 2002; 40:886.
5. Li PK, Szeto CC, Piraino B, de Arteaga J, et al. ISPD Peritonitis Recommendations: 2016 Update on Prevention and Treatment. Perit Dial Int. 2016; 36(5):481-508.
6. Boudville N, Blake PG. Volume Status and Fluid Overload in Peritoneal Dialysis. In: Handbook of Dialysis, 5th edition, edited by Daugirdas JT, Blake PG, Ing TS, Lippincott Williams & Wilkins, Philadelphia. 2015:483-9.
7. Aguiar PV, Santos O, Teixeira L, Silva F, Azevedo P, Vidinha J, et al. Overhydration prevalence in peritoneal dialysis - A 2 year longitudinal analysis. Nefrologia. 2015; 35(2):189-96.
8. Manfredi SR, Nadaletto MAJ, Draibe SA, Canziani MEF. Técnicas Dialíticas na Doença Renal Crônica. In: Guias de Medicina Ambulatorial e Hospitalar da UNIFESP-EPM: Nefrologia, 3th edition, edited by Ajzen H, Schor N, Manole, Barueri, SP. 2011:449-59.
9. Oliver MJ, Quinn RR. Selecting Peritoneal Dialysis in the Older Dialysis Population. Perit Dial Int. 2015; 35(6):618-21.
10. Clinical practice guidelines for peritoneal dialysis adequacy. Am J Kidney Dis. 2006; 48 Suppl 1:S98-129.
11. Beddhu S, Baird B, Ma X, Cheung AK, Greene T. Serum alkaline phosphatase and mortality in hemodialysis patients. Clin Nephrol. 2010; 74(2):91-96.
12. Shantouf R, Kovesdy CP, Kim Y, et al. Association of serum alkaline phosphatase with coronary artery calcification in maintenance hemodialysis patients. Clin J Am Soc Nephrol. 2009; 4(6):1106-1114.
13. Ates K, Ates A, Ekmekci Y, Nergizoglu G. The time course of serum C-reactive protein is more predictive of mortality than its baseline level in peritoneal dialysis patients. Perit Dial Int. 2005; 25(3):256-268.
14. Jones S, Holmes CJ, Mackenzie RK, Stead R, Coles GA, Williams JD, et al. Continuous dialysis with bicarbonate/lactate-buffered peritoneal dialysis fluids results in a long-term improvement in ex vivo peritoneal macrophage function. J Am Soc Nephrol. 2002; 13(Suppl 1):S97-103.
15. Hekking LH, Zareie M, Driesprong BA, et al. Better preservation of peritoneal morphologic features and defense in rats after long-term exposure to a bicarbonate/lactate-buffered solution. J Am Soc Nephrol. 2001; 12(12):2775-2786.
16. Liu FX, Gao X, Inglese G, Chuengsaman P, Pecoits-Filho R, Yu A. A global overview of the impact of peritoneal dialysis first or favored policies: an opinion. Perit Dial Int. 2014; 35(4):406-420.
17. Li PK, Szeto CC, Piraino B, Bernardini J, Figueiredo AE, Gupta A, et al. Peritoneal dialysis-related infections recommendations: 2010 update. Perit Dial Int. 2010; 30(4):393-423.
18. Sipahioglu MH, Aybal A, Unal A, Tokgoz B, Oymak O, Utas C. Patient and technique survival and factors affecting mortality on peritoneal dialysis in Turkey: 12 years' experience in a single center. Perit Dial Int. 2008; 28(3):238-245.
19. Yi C, Yang X, Guo Q, Jiang Z, Lin J, Cai J, et al. The clinical features of first episode of peritonitis in patients with long-term peritoneal dialysis. Chin J Nephrol. 2011; 27(10):715-719.
20. Bello AK, Levin A, Lunney M, et al. Status of care for end stage kidney disease in countries and regions worldwide: international cross sectional survey. BMJ 2019; 367:l5873.
21. Weinhandl ED, Foley RN, Gilbertson DT, Arneson TJ, Snyder JJ, Collins AJ. Propensity-matched mortality comparison of incident hemodialysis and peritoneal dialysis patients. J Am Soc Nephrol 2010; 21:499-506.
22. He L, Liu X, Li Z, et al. Rate of decline of residual kidney function before and after the start of peritoneal dialysis. Perit Dial Int 2016; 36:334-339.
23. Hsu CC, Huang CC, Chang YC, Chen JS, Tsai WC, Wang KY. A comparison of quality of life between patients treated with different dialysis modalities in Taiwan. PLoS One 2020; 15:e0227297.
24. Shaldon S, Koch KM, Quellhorst E, Lonnemann G, Dinarello CA. CAPD is a second-class treatment. Contrib Nephrol 1985; 44:163-172.
25. Khalid U, Zaidi A, Cheang A, et al. 'Educational' deprivation is associated with PD peritonitis. Perit Dial Int 2018; 38:251-256.
26. Plantinga LC, Fink NE, Finkelstein FO, Powe NR, Jaar BG. Association of peritoneal dialysis clinic size with clinical outcomes. Perit Dial Int 2009; 29:285-291.
27. Chang JH, Oh J, Park SK, et al. Frequent patient retraining at home reduces the risks of peritoneal dialysis-related infections: a randomised study. Sci Rep 2018; 8:12919.
28. Han SH, Lee SC, Ahn SV, et al. Improving outcome of CAPD: twenty-five years' experience in a single Korean center. Perit Dial Int 2007; 27:432-440.
29. Abe M, Hamano T, Hoshino J, et al. Predictors of outcomes in patients on peritoneal dialysis: a 2-year nationwide cohort study. Sci Rep 2019; 9:3967.
30. Brown EA, Blake PG, Boudville N, et al. International Society for Peritoneal Dialysis practice recommendations: prescribing high-quality goal-directed peritoneal dialysis. Perit Dial Int 2020; 40:244-253.
31. Lee Y, Chung SW, Park S, et al. Incremental peritoneal dialysis may be beneficial for preserving residual renal function compared to full-dose peritoneal dialysis. Sci Rep 2019; 9:10105.

1. Access through OpenAthens 2. Credentials/SubscriptionFor any technique error please contact us.
Who Can Become a Reviewer?
Any expert in the article's research field can become a reviewer with American Journal of Biomedicine. Editors might ask you to look at a specific aspect of an article,... Find out more
  • Research Article
    American Journal of BioMedicine Volume 10, Issue 2, pages 72-81
    Received February 11, 2022; revised May 09, 2022; accepted May 20, 2022; published May 30, 2022.


    How to cite this article
    Sung W, Choi J. Postoperative mortality in peritoneal dialysis: analytic study in patients with peritonitis. American Journal of BioMedicine. 2022; 10(2): 72-81.
    Research Article
    1. Abstract
    2. Introduction
    3. Discussion
    4. References

    Article metric